132 results
Service experience plays an important role in establishing trust and confidence in the health system and influences the use of services by clients and caregivers. In this video, learn about what...
Immunization Service Experience includes the factors within and beyond the interactions between a health worker and an immunization client which influence the delivery and experience of the...
Immunization service experience (SE) includes the factors within and beyond the interactions between a health worker and an immunization client which influence the delivery and experience of the...
Immunization Service Experience includes the factors within and beyond the interactions between a health worker and an immunization client which influence the delivery and experience of the...
Immunization service experience includes the factors within and beyond the interactions between a health worker and an immunization client which influence the delivery and experience of the...
Suggested minimum set of analysis for informing:
Joint Appraisals
Review of Health System Strengthening support during country missions
Strategic in-country discussions relating to a new proposal...
Au cours de ce webinaire, vous découvrirez la stratégie de Gavi en matière de chaîne d'approvisionnement pour la vaccination (2021-2025), qui soutient la vision de Gavi Alliance et le Programme...
In this webinar you will hear about Gavi's immunisation supply chain strategy (2021-2025), which supports the vision of the Gavi Alliance and the Global Immunisation Agenda 2030 of leaving no one...
This slide deck includes information on various potential criteria to assess rotavirus vaccines. Those include availability for WHO prequalified rotavirus vaccines supported by Gavi; efficacy, safety...
Allows access to up-to-date and comprehensive information on Gavi-supported vaccines (including Rotavirus, PCV, HPV and TCV). Provides an overview of WHO prequalified products for the vaccine groups...
Au cours de ce webinaire, vous découvrirez la stratégie de Gavi en matière de chaîne d'approvisionnement pour la vaccination (2021-2025), qui soutient la vision de Gavi Alliance et le Programme...
In this webinar you will hear about Gavi's immunisation supply chain strategy (2021-2025), which supports the vision of the Gavi Alliance and the Global Immunisation Agenda 2030 of leaving no one...
Contenido: En esta presentación se resumen las recomendaciones y consideraciones más recientes de la OMS para elegir productos vacunales contra la COVID-19 con la lista de la OMS para uso de...
New vaccines are much more expensive than older vaccines. Two of the newest vaccines -- against pneumonia and diarrhoea -- account for more than 70% of the total cost of vaccinating a child. Reasons...
There are 17 countries currently receiving support and subsidies from GAVI that are due to lose this support by 2016, a process called "graduation." More countries are entering the graduation process...
Provides examples of gender related barriers and possible interventions to tackle them.
An overview of demand generation and its key elements and guidance on the country dialogue and process for developing the demand generation component of Gavi HSIS proposals. It outlines five main...
Contenu : Ce jeu de diapositives résume les derniers facteurs à prendre en considération et recommandations de l’OMS quant au choix des produits vaccinaux contre la COVID-19 avec la liste...
Content: This slide set summarizes WHO latest recommendations and considerations for choosing COVID-19 vaccine products with WHO Emergency Use List (EUL) (currently available under COVAX) as of 18...
New guidance for managing health care waste produced by your immunisation program: GAVI presentation
This is the 1st presentation of a TechNet webinar lead by Gavi and UNICEF on health care waste management with a focus on the immunisation program. As immunisation increasingly reaches more people,...
An actionable guide to processes and standards for cold chain stakeholders. This document provides guidance and rationale for key stakeholders throughout the cold chain (such as EPI managers, cold...
The CCEOP Technology Guide is a resource for country decision makers to aid in their selection of cold chain equipment that fits their local needs and context and includes an overview of all...
Synthesis report covering a cross-country analysis of data review teams interventions carried out by CHAI, John Snow, Inc., and VillageReach. Surfaces three principles and eight recommendations for...
The following report displays data and figures on the introduction status of pneumococcal conjugate vaccine (PCV), rotavirus vaccine, and inactivated polio vaccine (IPV) both globally and in 73 Gavi...
VillageReach describes how the supply chain design process provides a good opportunity to investigate and address potential inequities. VillageReach documented its framework to help identify...
VillageReach documents how supply chain design increased access to vaccines in Equateur province, DRC. An independent study conducted by Acasus in July 2018 verified that average monthly consumption...
The following report displays data and figures on the introduction status of pneumococcal conjugate vaccine (PCV), rotavirus vaccine, and inactivated polio vaccine (IPV) both globally and in 73 Gavi...
This is a global standards document for immunisation supply chain (iSC) information systems. The objectives of this Target Software Standards (TSS) are to ensure countries have access to:
1....
The following report displays data and figures on the introduction status of pneumococcal conjugate vaccine (PCV), rotavirus vaccine, and inactivated polio vaccine (IPV) both globally and in 73 Gavi...
The Gavi CCEOP Technology Guide aims to provide you with clear advice on new CCE technologies to help you make purchasing decisions. It is intended for use in health facilities and lower levels of...
The following report displays data and figures on the introduction status of pneumococcal conjugate vaccine (PCV), rotavirus vaccine, and inactivated polio vaccine (IPV) both globally and in 73 Gavi...
Nigeria over the last few years has been unable to fully fund its immunization needs. This was largely attributed to dwindling national resources, rising cost of vaccine, inadequate yearly budgetary...
The Sabin Vaccine Institute, in collaboration with international partners and the Government of Georgia, organized a Workshop on Immunization Legislation that gathered the three European countries of...
As countries expand immunisation programmes to include new vaccines and ensure increased coverage and equity, existing and potential constraints exist within the supply chain systems to manage an...
Руководство по оперативному развертыванию для стран.
Guide de déploiement opérationnel à l’intention des pays.
Guía de implantación operativa para los países.
Objective: To synthesise lessons learnt and determinants of success from human papillomavirus (HPV) vaccine demonstration projects and national programmes in low- and middle-income countries...
Gavi, the Vaccine Alliance, supports immunisation programmes in eligible countries to reach children with lifesaving vaccines. Dramatic improvement in the scale and performance of current cold chain...
Background: Gavi recommends solar refrigerators for vaccine storage in areas with less than eight hours of electricity per day, and WHO guidelines are more conservative. The question remains: Can...
Nigeria is the most populous country in Africa and in 2012 was suffering some of the lowest vaccination rates in the World. A combination of factors had resulted in a dysfunctional immunization cold...
Introduction: The vaccine vial monitor (VVM) registers cumulative heat exposure on vaccines over time. As low- and lower-middle-income countries transition beyond support from the Global Alliance for...
Gavi, the Vaccine Alliance is a global public-private partnership with the goal of supporting the national governments of low-income countries in their efforts to increase equal access to vaccines....
In many countries, one of the common factors limiting full and equitable access to effective immunization is the existence of gaps in cold chain and logistics (CCL) systems. This article focuses on...
Immunization supply chains—the network of staff, equipment, vehicles, and data needed to get vaccines safely from the manufacturer to the people who need them—were first developed in the late...
The Democratic Republic of Congo (the DRC) has rapidly improved the quality of social services and infrastructure in general, and the health sector in particular in recent years. It is not always...
Members of Gavi, the Vaccine Alliance, have articulated the complex, interdependencies inherent to supply chain systems and identified five fundamental areas that must be improved as we develop the...
Introduction
National immunization systems are important for reducing vaccine preventable diseases.1 However, in many resource-constrained countries, such systems need to be improved. This paper...
Since the launch of the global Expanded Programme on Immunization (EPI) in 1974, vaccination against 6 diseases (tuberculosis, polio, diphtheria, tetanus, pertussis, and measles) has prevented...
5.9 million children under 5 died in 2015, the majority from vaccine preventable diseases. Decades of effort & investment from donor countries have driven significant progress but, in the final year...
Home-based records (HBRs) are an important tool for recording and communicating within primary healthcare service delivery. Unfortunately, HBRs are currently unable to fulfil their intended purpose...
This document aims to establish a common vaccine innovation vocabulary to help ensure clarity in communications about innovations applied to vaccine products to increase their programmatic...
Zambia had a population of just over 13 million in 2010 of which 60.5% lived in rural areas. The total fertility rate is high at 5.9 per woman and higher in rural areas. Zambia is classified as a...
In Uganda and other countries, accurate data on the costs of immunization with routine and new vaccines is needed to improve country level planning and financing for immunization, as well as to...
The following report displays data and figures on the introduction status of pneumococcal conjugate vaccine (PCV), rotavirus vaccine, and inactivated polio vaccine (IPV) both globally and in 73 Gavi...
Nearly all of the 500,000 new cases of cervical cancer and 270,000 deaths occur in middle or lower income countries. Yet the two most prevalent HPV vaccines are unaffordable to most. Even prices to...
Since the global Expanded Program on Immunization (EPI) was launched in 1974, vaccination against six diseases (tuberculosis, polio, diphtheria, tetanus, pertussis, and measles) has prevented...
Since 2011, a five-year strategy has guided Gavi’s mission to save children’s lives and protect people’s health by increasing access to immunisation. In this edition of its Annual Progress...
As the pace of vaccine uptake accelerates globally, there is a need to document low-income country experiences with vaccine introductions. Over the course of five years, the government of Rwanda...
Technet was relaunched at the 2001 conference as Technet21. The New Delhi 2001 meeting, organized back-to-back with SIGN, welcomed a total of 107 participants including 23 participants representing...
Supported by GAVI Alliance, measles-rubella vaccination was introduced in Vietnam in 2014, involving a mass campaign among 1-14 year olds and routine immunization of children aged 9 months. We...
Few countries in Africa currently include rubella-containing vaccination (RCV) in their immunization schedule. The Global Alliance for Vaccines Initiative (GAVI) recently opened a funding window that...
The following report displays data and figures on the introduction status of pneumococcal conjugate vaccine (PCV), rotavirus vaccine, and inactivated polio vaccine (IPV) both globally and in 73 Gavi...
BACKGROUND:
Introduction of new vaccines in low- and lower middle-income countries has accelerated since Gavi, the Vaccine Alliance was established in 2000. This study sought to (i) estimate the...
Introduction: Under five mortality in Zambia is unacceptably high and diarrhoea is the third leading contributor. The Programme for Awareness and Elimination of Diarrhoea (PAED) sought to support the...
Immunisation is now widely recognised as one of the most efficient, successful, and cost-effective health investments in history, but despite a substantial effort over the past 50 years, nearly one...
In May, 1974, WHO launched the Expanded Programme on Immunization—the global programme to immunise children worldwide with a set of (at the time) six core vaccines. 40 years on, the GAVI Alliance...
Vaccines are extremely powerful disease prevention agents and have the potential to save millions of lives. Tremendous scientific progress has been made in the past decade with several new vaccines...
Lauded for getting specific health issues onto national and international agendas and for their potential to improve value for money and outcomes, public-private global health initiatives (GHIs) have...
The international community has successfully promoted childhood vaccination as an essential public health intervention. This has been accomplished through efforts such as the World Health...
Introduction: Origins and Definitions
International cooperation for purposes of infectious and tropical disease control goes back to at least the 14th century, when early concepts of quarantine...
Haemophilus influenzae type b (Hib) conjugate vaccine, delivered as a three-dose series without a booster, was introduced into the childhood vaccination programme in Kenya in 2001. The duration of...
GAVI’s focus on reducing inequities in access to vaccines, immunization, and GAVI funds, − both between and within countries - has changed over time. This paper charts that evolution.
The scorecard looks at countries’ immunisation progress and the need to reach every last child with immunisation services.
This evaluation assesses the extent to which the Advanced Market Commitment (AMC) pilot has achieved its stated objectives and the overarching goal to “reduce morbidity and mortality from...
The Gambian PCV programme reduced the incidence of invasive pneumococcal disease in children aged 2–59 months by around 55%. Further surveillance is needed to ascertain the maximum effect of the...
Since the mid-2000s low- and lower-middle-income countries have been focusing on developing and using evidence for immunization policy making, with an increasing emphasis on cost-effectiveness...
A goal of the Global Vaccine Action Plan, led by the World Health Organization, is country ownership by 2020, defined here as the point when a country fully finances its routine immunization program...
Governments in resource-poor settings have traditionally relied on external donor support for immunization. Under the Global Vaccine Action Plan, adopted in 2014, countries have committed to...
Gavi, the Vaccine Alliance, was created in 2000 to accelerate the introduction of new and underused vaccines in lower-income countries. The period 2000–15 was marked by the rapid uptake of new...
In the 2012 Global Vaccine Action Plan, development assistance partners committed to providing sustainable financing for vaccines and expanding vaccination coverage to all children in low- and...
Pneumococcal conjugate vaccines (PCVs) are safe and effective for reducing illness and deaths caused by Streptococcus pneumoniae (1). Recommendations for PCV use from the World Health Organization...
With so many new developments underway, it is critical to use a structured approach to select the right equipment. This guide aims to provide you with clear advice on new CCE technologies to help you...
This report presents the findings of the Outcomes and Impact evaluation for the Pilot Advance Market Commitment (AMC) for Pneumococcal Vaccines. This evaluation was conducted in 2015 by The Boston...
An analysis of return on investment can help policy makers support, optimize, and advocate for the expansion of immunization programs in the world’s poorest countries. We assessed the return on...
Middle-income countries (MICs) as a group are not only characterized by a wide range of gross national income (GNI) per capita (US $1026 to $12,475), but also by diversity in size, geography,...
The purpose, methods, data sources and assumptions behind the World Health Organization (WHO) Cervical Cancer Prevention and Control Costing (C4P) tool that was developed to assist low- and...
An analysis of return on investment can help policy makers support, optimize, and advocate for the expansion of immunization programs in the world’s poorest countries. We assessed the return on...
The number of admissions to hospital for diarrhoea and rotavirus in Rwanda fell substantially after rotavirus vaccine implementation, including among older children age-ineligible for vaccination,...
The Journal of Infectious Diseases supplement rightly focuses on the notion of integrated healthcare, which has a long history in public health. Integrated healthcare has been proposed to tackle the...
Evaluation of cost-effectiveness of live oral pentavalent reassortant rotavirus vaccine introduction
Globally, rotavirus gastroenteritis is the most common identifiable cause of severe diarrhea in children under 5. Recently introduced rotavirus vaccines from Merck & Co. and GlaxoSmithKline have the...
The continued presence of polio in northern India poses challenges to the interruption of wild poliovirus transmission and the management of poliovirus risks in the post-eradication era. We aimed to...
Rotavirus is the most common cause of severe diarrhoea worldwide. Vietnam is situated in the region of high rotavirus infection incidence and eligible for financial support to introduce rotavirus...
The phase 3 trial of the RTS,S/AS01 malaria vaccine candidate showed modest efficacy of the vaccine against Plasmodium falciparum malaria, but was not powered to assess mortality endpoints. Impact...